News
Glenmark Pharmaceuticals receives affirmation in credit rating from CRISIL
19-Sep-2025 | 10:33
Glenmark Pharmaceuticals announced that CRISIL has reaffirmed the credit rating for the bank loan facilities of Rs 1850 crore availed by the company at CRISIL AA/ CRISIL A1+. The outlook on the rating has been revised from Stable to Positive.
Powered by Capital Market - Live News